Associations of HLA genetic variants with carbamazepine‐induced cutaneous adverse drug reactions: An updated meta‐analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Associations of
HLA
genetic variants with carbamazepine‐induced cutaneous adverse drug reactions: An updated meta‐analysis
Authors
Keywords
-
Journal
CTS-Clinical and Translational Science
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-05-23
DOI
10.1111/cts.13291
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical and Epidemiological Features of Patients with Drug-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Iran: Different Points of Children from Adults
- (2022) Bahareh Abtahi-Naeini et al. International Journal of Pediatrics
- Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters
- (2021) Teresa Iannaccone et al. Pharmaceuticals
- Pharmacogenomics research and its clinical implementation in Thailand: Lessons learned from the resource-limited settings
- (2021) Chonlaphat Sukasem et al. Drug Metabolism and Pharmacokinetics
- Association between the HLA-B*1502 gene and mild maculopapular exanthema induced by antiepileptic drugs in Northwest China
- (2021) Nilupaer Shafeng et al. BMC Neurology
- Genetic variants associated with severe cutaneous adverse drug reactions induced by carbamazepine
- (2021) Nontaya Nakkam et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Genotyping HLA alleles to predict the development of Severe cutaneous adverse drug reactions (SCARs): state-of-the-art
- (2021) Thawinee Jantararoungtong et al. Expert Opinion on Drug Metabolism & Toxicology
- HLA Risk Alleles in Aromatic Antiepileptic Drug-Induced Maculopapular Exanthema
- (2021) Yi-Wu Shi et al. Frontiers in Pharmacology
- A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine
- (2021) Chiraphat Kloypan et al. Pharmaceuticals
- Association of carbamazepine-induced Stevens–Johnson syndrome/toxic epidermal necrolysis with the HLA-B75 serotype or HLA-B*15:21 allele in Filipino patients
- (2020) Francis Capule et al. PHARMACOGENOMICS JOURNAL
- Global Frequencies of Clinically Important HLA Alleles and Their Implications For the Cost‐Effectiveness of Preemptive Pharmacogenetic Testing
- (2020) Yitian Zhou et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The nationwide epidemiological survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan, 2016-2018
- (2020) Yuma Sunaga et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Association of cutaneous adverse drug reactions due to antiepileptic drugs with HLA alleles in a North Indian population
- (2019) Kavish Ihtisham et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- HLA‐B*57:01 confers genetic susceptibility to carbamazepine‐induced SJS/TEN in Europeans
- (2019) Maja Mockenhaupt et al. ALLERGY
- The HLA-B*15:02 polymorphism and Tegretol ® -induced serious cutaneous reactions in epilepsy: An updated systematic review and meta-analysis
- (2018) M. Chouchi et al. REVUE NEUROLOGIQUE
- Association between HLA-B Alleles and Carbamazepine-Induced Maculopapular Exanthema and Severe Cutaneous Reactions in Thai Patients
- (2018) Chonlaphat Sukasem et al. Journal of Immunology Research
- Association between the HLA-B alleles and carbamazepine-induced SJS/TEN: A meta-analysis
- (2017) Qianyu Wang et al. EPILEPSY RESEARCH
- The association of HLA B*15:02 allele and Stevens-Johnson syndrome/toxic epidermal necrolysis induced by aromatic anticonvulsant drugs in a South Indian population
- (2017) Keerankulangara Devi INTERNATIONAL JOURNAL OF DERMATOLOGY
- Severe cutaneous adverse reactions to drugs
- (2017) Tu Anh Duong et al. LANCET
- HLA-A*24:02 as a common risk factor for antiepileptic drug–induced cutaneous adverse reactions
- (2017) Yi-Wu Shi et al. NEUROLOGY
- HLA-A*31
- (2017) Amy Hui-Ping Khor et al. Pharmacogenetics and Genomics
- Tailoring of recommendations to reduce serious cutaneous adverse drug reactions: a pharmacogenomics approach
- (2017) Wei Chuen Tan-Koi et al. PHARMACOGENOMICS
- Association of the HLA-B alleles with carbamazepine-induced Stevens–Johnson syndrome/toxic epidermal necrolysis in the Javanese and Sundanese population of Indonesia: the important role of the HLA-B75 serotype
- (2017) Rika Yuliwulandari et al. PHARMACOGENOMICS
- Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/TEN are different from those found for the same AED-induced DRESS in the Spanish population
- (2017) Elena Ramírez et al. PHARMACOLOGICAL RESEARCH
- HLA-A*31:01 and carbamazepine-induced DRESS syndrom in a sample of North African population
- (2017) Kamilia Ksouda et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Morbidity and Mortality of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in United States Adults
- (2016) Derek Y. Hsu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A success story in pharmacogenomics: genetic ID card for SJS/TEN
- (2016) Chonlaphat Sukasem et al. PHARMACOGENOMICS
- Incidence of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Nationwide Population-Based Study Using National Health Insurance Database in Korea
- (2016) Min-Suk Yang et al. PLoS One
- Do HLA-A markers predict skin-reactions from aromatic antiepileptic drugs in a Norwegian population? A case control study
- (2015) Maryam Shirzadi et al. EPILEPSY RESEARCH
- Development of a simple genotyping method for the HLA-A*31:01-tagging SNP in Japanese
- (2015) Keiko Maekawa et al. PHARMACOGENOMICS
- Association ofABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA,and BAG6polymorphisms with the risk of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Chinese Han patients with epilepsy
- (2014) Xiao-Jing He et al. EPILEPSIA
- HLA-B*15:02 association with carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in an Indian population: a pooled-data analysis and meta-analysis
- (2014) Amy Hui-Ping Khor et al. EPILEPSIA
- Genetic predictors of Stevens–Johnson syndrome and toxic epidermal necrolysis induced by aromatic antiepileptic drugs among the Chinese Han population
- (2014) Wei Wang et al. EPILEPSY & BEHAVIOR
- HLA-B∗1502 is associated with carbamazepine induced Stevens–Johnson syndrome in North Indian population
- (2014) Ritu Aggarwal et al. HUMAN IMMUNOLOGY
- Association of HLA-B*1502 and *1511 allele with antiepileptic drug-induced Stevens-Johnson syndrome in central China
- (2014) Dan Sun et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- HLA-A*02:01:01/-B*35:01:01/-C*04:01:01 haplotype associated with lamotrigine-induced maculopapular exanthema in Mexican Mestizo patients
- (2014) Ingrid Fricke-Galindo et al. PHARMACOGENOMICS
- Association between the HLA-B*15:02 allele and carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Han individuals of northeastern China
- (2014) Xiao-Jing He et al. Pharmacological Reports
- Association of carbamazepine-induced severe cutaneous drug reactions and HLA-B*1502 allele status, and dose and treatment duration in paediatric neurology patients in Singapore
- (2013) K. W. Chong et al. ARCHIVES OF DISEASE IN CHILDHOOD
- HLA-A*31:01 and HLA-B*15:02 as Genetic Markers for Carbamazepine Hypersensitivity in Children
- (2013) U Amstutz et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese
- (2013) Ying-Kit Cheung et al. EPILEPSIA
- Predictive markers for carbamazepine and lamotrigine-induced maculopapular exanthema in Han Chinese
- (2013) Li-Juan Li et al. EPILEPSY RESEARCH
- Genotype–phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: Strength and clinical correlations
- (2013) Yi-Hsin Hsiao et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- HLA alleles and hypersensitivity to carbamazepine
- (2013) Sandeep Grover et al. Pharmacogenetics and Genomics
- HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis
- (2013) E Genin et al. PHARMACOGENOMICS JOURNAL
- Relationship Between theHLA-B*1502Allele and Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
- (2013) Wimonchat Tangamornsuksan et al. JAMA Dermatology
- Association between HLA and Stevens-Johnson Syndrome Induced by Carbamazepine in Southern Han Chinese: Genetic Markers besides B*1502?
- (2012) Yi-Wu Shi et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- HLA Genotype and Carbamazepine-Induced Cutaneous Adverse Drug Reactions: A Systematic Review
- (2012) V L Yip et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore
- (2012) D. Dong et al. NEUROLOGY
- Toxic epidermal necrolysis and Stevens-Johnson syndrome in South Africa: a 3-year prospective study
- (2012) S. M. H. Kannenberg et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans
- (2011) Sae-Hoon Kim et al. EPILEPSY RESEARCH
- Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients
- (2011) Yan Zhang et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population
- (2011) Choong-Chor Chang et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome
- (2011) Tai-Ming Ko et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- HLA-A31 strongly associates with carbamazepine-induced adverse drug reactions but not with carbamazepine-induced lymphocyte proliferation in a Japanese population
- (2011) Hiroyuki NIIHARA et al. JOURNAL OF DERMATOLOGY
- HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
- (2011) Mark McCormack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland
- (2011) Qian Wang et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- HLA-B*1502 Strongly Predicts Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Thai Patients with Neuropathic Pain
- (2011) Kongkiat Kulkantrakorn et al. Pain Practice
- Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population
- (2010) Wichittra Tassaneeyakul et al. EPILEPSIA
- Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China
- (2010) X.T. Wu et al. EPILEPSY & BEHAVIOR
- Association of HLA-BFNx011502 allele and carbamazepine-inducedStevens-Johnson syndromeamong Indians
- (2009) TimirY Mehta et al. Indian Journal of Dermatology Venereology & Leprology
- Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population
- (2008) Chaichon Locharernkul et al. EPILEPSIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now